Macrophage migration inhibitory factor and autism spectrum disorders.
Macrophage migration inhibitory factor and autism spectrum disorders.
复制标题
DOI:
10.1542/peds.2007-3604
复制
发表时间:
2008-08
期刊:
影响因子:
8
通讯作者:
Bucala R
中科院分区:
文献类型:
--
作者:
Grigorenko EL;Han SS;Yrigollen CM;Leng L;Mizue Y;Anderson GM;Mulder EJ;de Bildt A;Minderaa RB;Volkmar FR;Chang JT;Bucala R
Autism-spectrum disorders (ASD) are childhood neurodevelopmental disorders characterized by social and communicative impairment and repetitive and stereotypical behavior. Macrophage migration inhibitory factor (MIF) is an upstream regulator of innate immunity that promotes monocyte/macrophage activation responses by increasing the expression of Toll-like receptors and inhibiting activation-induced apoptosis. Based on results of prior genetic linkage studies and reported altered innate immune response in ASD, we hypothesized that MIF could represent a candidate gene for ASD or its diagnostic components. Genetic association between ASD and MIF was investigated in two independent sets of families of probands with ASD, from USA (527 participants from 152 families) and Holland (532 participants from 183 families). Probands and their siblings, when available, were evaluated with clinical instruments used for ASD diagnoses. Genotyping was performed for two polymorphisms in the promoter region of the MIF gene in both samples sequentially. In addition, MIF plasma analyses were carried out in a subset of Dutch patients from whom plasma was available. There were genetic associations between known functional polymorphisms in the promoter for MIF and ASD-related behaviors. Also, probands with ASD exhibited higher circulating MIF levels than did their unaffected siblings; the amount of MIF in the plasma correlated with the severity of multiple ASD symptoms. These results identify MIF as a susceptibility gene for ASD. Further research is warranted on the precise relationship between MIF and the behavioral components of ASD, the mechanism by which MIF contributes to ASD pathogenesis, and the clinical utility of MIF genotyping.
登录
查看更多内容
影响因子:
5.2
作者:
Horvath, S;Xu, X;Laird, NM
通讯作者:
Laird, NM
影响因子:
5
作者:
Baugh, JA;Chitnis, S;Bucala, R
通讯作者:
Bucala, R
影响因子:
5.1
作者:
Connolly, AM;Chez, MG;Deuel, RK
通讯作者:
Deuel, RK
DOI:
10.1007/bf01537954
发表时间:
1971-01-01
期刊:
JOURNAL OF AUTISM AND CHILDHOOD SCHIZOPHRENIA
影响因子:
--
作者:
MONEY, J;BOBROW, NA;CLARKE, FC
通讯作者:
CLARKE, FC
影响因子:
64.8
作者:
Chanock, Stephen J.;Manolio, Teri;Collins, Francis S.
通讯作者:
Collins, Francis S.